The GBS group also displayed a significantly higher serum level of MMP9 (Fig. 1B, 153.74±35.68 ng/mL) than the control group (52.70±5.67 ng/mL, P = 0.013). Here, MMP9 is linked to Guillain-Barre syndrome.